Abstract
There has been recent interest in dry powder inhaled mannitol as a therapeutic agent in patients with cystic fibrosis (CF). It is has been shown to increase mucociliary clearance (MCC) by rehydrating the airway. To date there have been no studies exclusively in children with CF examining the effect of dry powder mannitol on the airways. The aim of this study was to determine acute tolerability of inhaled mannitol in children with CF.
Original language | English |
---|---|
Pages (from-to) | 1078-84 |
Number of pages | 7 |
Journal | Pediatric Pulmonology |
Volume | 43 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2008 |